Susquehanna International Group’s iShares Evolved U.S. Innovative Healthcare ETF IEIH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-9,011
Closed -$297K 14781
2022
Q2
$297K Sell
9,011
-9,315
-51% -$306K ﹤0.01% 9588
2022
Q1
$628K Buy
+18,326
New +$606K ﹤0.01% 8342
2020
Q3
Sell
-15,398
Closed -$461K 11381
2020
Q2
$461K Buy
+15,398
New +$442K ﹤0.01% 7539

Susquehanna International Group's IEIH Position: Q3 2022 in Review

Susquehanna International Group sold out of iShares Evolved U.S. Innovative Healthcare ETF (IEIH) in Q3 2022, closing a stake of 9,011 shares — an estimated $297K sold.

Susquehanna International Group first reported a position in IEIH in Q2 2020 and held it in 3 quarters. The position peaked at $628K in Q1 2022. 0 funds tracked by Wall St. Rank hold IEIH as of Q3 2022.

  • Susquehanna International Group reported no remaining iShares Evolved U.S. Innovative Healthcare ETF position as of Q3 2022 after selling out during the quarter.
  • Susquehanna International Group sold 9,011 iShares Evolved U.S. Innovative Healthcare ETF shares in Q3 2022, an estimated $297K.
  • Susquehanna International Group first reported a position in iShares Evolved U.S. Innovative Healthcare ETF in Q2 2020 and held it in 3 quarters.
  • Susquehanna International Group's iShares Evolved U.S. Innovative Healthcare ETF position peaked at $628K in Q1 2022.
  • 0 funds tracked by Wall St. Rank held iShares Evolved U.S. Innovative Healthcare ETF as of Q3 2022.

Based on Susquehanna International Group's 13F filing for Q3 2022, filed 14 Nov 2022.